JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

简称 J CARDIOVASC PHARM ·UNITED STATES ·出版周期 Monthly ·年均收录 121 篇

2.2

最新影响因子

3.90%

自引率

约97.5%

投稿难度

平均1月

审稿周期

期刊简介

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY是一本专注于心血管药理学研究的国际期刊，ISSN号为0160-2446，由美国出版商Lippincott Williams & Wilkins出版，出版地为美国，出版周期为月刊。该期刊的影响因子根据年份有所不同，近年保持在中等水平，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学或药理学领域的3区或4区。杂志的发文特点集中于心血管疾病的药物治疗机制、新药开发、药效学与药代动力学研究，以及临床前和临床试验成果，涵盖高血压、心力衰竭、动脉粥样硬化等主题。其质量体现在审稿严谨、内容专业，但影响因子相对不高可能反映其学术影响力有限；风险方面需注意投稿周期较长或竞争较激烈，同时需确保研究符合其偏重的基础与临床结合的方向。总体而言，该期刊适合心血管药理学领域的研究者投稿，尤其重视实验与临床转化的原创性研究。

影响因子趋势

近期发表

Effect of Sacubitril/Valsartan versus Angiotensin Receptor Blocker or Calcium Channel Blockers on Ambulatory Blood Pressure and Safety in Hypertensive Patients: A Meta-Analysis of Randomized Controlled Trials 2026-09-18

Efficacy of Cardioprotective Drugs in Cancer Patients Receiving Anthracyclines: A Pairwise Meta-Analysis and Network Meta-Analysis 2026-09-08

Effective Protection Against Alcohol-Related Cardiac Damage: Dapagliflozin 2026-09-04

Asiatic Acid Mitigates PM2.5-Elicited Cardiomyocyte Pyroptosis via Suppression of mtDNA-Driven cGAS-STING-NLRP3 Signaling 2026-07-06

Reversal of the Anticoagulant Effect of Milvexian by 4-Factor PCC and rFVIIa in Healthy Participants: A Two-Part, Randomized, Crossover Study 2026-07-06

Direct Oral Anticoagulants Versus Warfarin on Coronary Plaque in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials 2025-12-16

Targeting Myocardial Energetics in Nonobstructive Hypertrophic Cardiomyopathy: The Role of Ninerafaxstat 2026-03-17

Effect of EET-A Treatment on Cardiac Hypertrophy Induced by Isoproterenol in Sprague-Dawley Rats 2026-06-26

Fluoropyrimidine Cardiotoxicity: Role of Uridine Triacetate and Pharmacogenomic Insights from a Case of 5-FU–Induced Cardiogenic Shock 2026-07-06

Clopidogrel Resistance in Patients With Ischemic Stroke: Current Insights, Risk Factors, and the Role of Platelet Function Testing—A Narrative Review 2026-07-23